You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Elysium Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ELYSIUM, and what generic and branded alternatives to ELYSIUM drugs are available?

ELYSIUM has four approved drugs.



Summary for Elysium
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Elysium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elysium POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202071-001 Dec 28, 2012 OTC No No ⤷  Sign Up ⤷  Sign Up
Elysium TOLTERODINE TARTRATE tolterodine tartrate TABLET;ORAL 210775-002 Dec 30, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up
Elysium TOLTERODINE TARTRATE tolterodine tartrate TABLET;ORAL 210775-001 Dec 30, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up
Elysium CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 209108-001 Oct 16, 2018 AA RX No No ⤷  Sign Up ⤷  Sign Up
Elysium AMANTADINE HYDROCHLORIDE amantadine hydrochloride SYRUP;ORAL 214178-001 Aug 20, 2021 AA RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.